Balaxi Pharmaceuticals Limited (NSE:BALAXI)

Balaxi Pharmaceuticals Revenue

Balaxi Pharmaceuticals had revenue of 806.82M INR in the quarter ending June 30, 2026, with 14.05% growth. This brings the company's revenue in the last twelve months to 2.80B, down -5.90% year-over-year. In the fiscal year ending March 31, 2026, Balaxi Pharmaceuticals had annual revenue of 2.70B, down -7.65%.

• Revenue (ttm): 2.80B
• Revenue Growth: -5.90%
• P/S Ratio: 0.46
• Revenue / Employee: 5.60M
• Employees: 500
• Market Cap: 1.29B

Revenue Chart

Chart

Chart

Revenue History

Fiscal Year End	Revenue	Change	Growth
Mar 31, 2026	2.70B	-223.88M	-7.65%
Mar 31, 2025	2.93B	512.67M	21.25%
Mar 31, 2024	2.41B	-951.38M	-28.28%
Mar 31, 2023	3.36B	570.45M	20.42%
Mar 31, 2022	2.79B	480.55M	20.77%

Data Source: S&P Global Market Intelligence Last updated: Aug 5, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Sep 6, 2026

Data Sources Report a data error